Detalles de la búsqueda
1.
Increased risk of cutaneous immune-related adverse events in patients treated with talimogene laherparepvec and immune checkpoint inhibitors: A multi-hospital cohort study.
J Am Acad Dermatol
; 88(6): 1265-1270, 2023 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-36944564
2.
Benefit and toxicity of programmed death-1 blockade vary by ethnicity in patients with advanced melanoma: an international multicentre observational study.
Br J Dermatol
; 187(3): 401-410, 2022 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-35293617
3.
Clinical features of acute kidney injury in patients receiving dabrafenib and trametinib.
Nephrol Dial Transplant
; 37(3): 507-514, 2022 02 25.
Artículo
en Inglés
| MEDLINE | ID: mdl-33355659
4.
Early Use of High-Dose Glucocorticoid for the Management of irAE Is Associated with Poorer Survival in Patients with Advanced Melanoma Treated with Anti-PD-1 Monotherapy.
Clin Cancer Res
; 27(21): 5993-6000, 2021 11 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-34376536
5.
Acute Kidney Injury Following Encorafenib and Binimetinib for Metastatic Melanoma.
Kidney Med
; 2(3): 373-375, 2020.
Artículo
en Inglés
| MEDLINE | ID: mdl-32734258
Resultados
1 -
5
de 5
1
Próxima >
>>